- Home
- SAVA vs FRD Comparison
SAVA vs FRD Comparison
Compare SAVA & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- FRD
- Stock Information
- Founded
- SAVA 1998
- FRD 1965
- Country
- SAVA United States
- FRD United States
- Employees
- SAVA N/A
- FRD N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- SAVA Health Care
- FRD Industrials
- Exchange
- SAVA Nasdaq
- FRD Nasdaq
- Market Cap
- SAVA 70.5M
- FRD 119.5M
- IPO Year
- SAVA N/A
- FRD N/A
- Fundamental
- Price
- SAVA $1.76
- FRD $15.90
- Analyst Decision
- SAVA Buy
- FRD
- Analyst Count
- SAVA 3
- FRD 0
- Target Price
- SAVA $54.50
- FRD N/A
- AVG Volume (30 Days)
- SAVA 807.5K
- FRD 20.1K
- Earning Date
- SAVA 05-08-2025
- FRD 06-10-2025
- Dividend Yield
- SAVA N/A
- FRD 1.00%
- EPS Growth
- SAVA N/A
- FRD N/A
- EPS
- SAVA N/A
- FRD 0.81
- Revenue
- SAVA N/A
- FRD $447,616,000.00
- Revenue This Year
- SAVA N/A
- FRD N/A
- Revenue Next Year
- SAVA N/A
- FRD N/A
- P/E Ratio
- SAVA N/A
- FRD $19.70
- Revenue Growth
- SAVA N/A
- FRD N/A
- 52 Week Low
- SAVA $1.15
- FRD $12.24
- 52 Week High
- SAVA $42.20
- FRD $19.18
- Technical
- Relative Strength Index (RSI)
- SAVA 54.92
- FRD 51.85
- Support Level
- SAVA $1.45
- FRD $14.00
- Resistance Level
- SAVA $1.67
- FRD $17.73
- Average True Range (ATR)
- SAVA 0.11
- FRD 0.69
- MACD
- SAVA 0.05
- FRD -0.12
- Stochastic Oscillator
- SAVA 87.50
- FRD 68.56
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.